AHL Partners’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

AHL Partners’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$853K	Sell	10,829 -13,080	-55%	-$1.09M	0.01%	929
2017 Q3	$2.21M	Buy	23,909 +16,464	+221%	+$1.58M	0.04%	643
2017 Q2	$842K	Buy	+7,445	New	+$832K	0.02%	831
2016 Q1	–	Sell	-7,289	Closed	-$1.04M	–	874
2015 Q4	$1.04M	Buy	7,289 +3,027	+71%	+$349K	0.08%	357
2015 Q3	$383K	Sell	4,262 -28,229	-87%	-$2.98M	0.06%	484
2015 Q2	$3.74M	Buy	+32,491	New	+$3.41M	0.15%	315

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CGI

Comgest Global Investors Paris, France $4.59B AUM 12.96% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

AHL Partners's CBPO Position: Q4 2017 in Review

AHL Partners reduced its China Biologic Products Holdings, Inc. (CBPO) stake by 55% in Q4 2017, selling an estimated $1.09M and leaving 10,829 shares worth $853K. The position accounts for 0.01% of the portfolio, ranked #929.

AHL Partners first reported a position in CBPO in Q2 2015 and has held it in 6 quarters since. The position peaked at $3.74M in Q2 2015. 93 funds tracked by Wall St. Rank hold CBPO as of Q4 2017.

AHL Partners held 10,829 shares of China Biologic Products Holdings, Inc. worth $853K as of Q4 2017.
AHL Partners sold 13,080 China Biologic Products Holdings, Inc. shares in Q4 2017, an estimated $1.09M.
China Biologic Products Holdings, Inc. made up 0.01% of AHL Partners's portfolio in Q4 2017, its #929 holding.
AHL Partners first reported a position in China Biologic Products Holdings, Inc. in Q2 2015 and has held it in 6 quarters since.
AHL Partners's China Biologic Products Holdings, Inc. position peaked at $3.74M in Q2 2015.
93 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.